NICE to review guidance on hypertension treatments
September 22, 2005Research and Development
NICE has set up a specialist advisory group to review new data which could lead to thousands of heart patients …
New data gives Seretide upper hand in respiratory battle
September 20, 2005Sales and Marketing
Seretide's domination in the global respiratory market looks set to be bolstered by a new head to head study with …
Biotechs back change to UK pricing system
September 16, 2005The current UK medicines pricing system discriminates against smaller biotech companies, and should be altered to take this into account, …
New NHS leaders in Alzheimer’s research and development
September 15, 2005A new NHS team has been set up to accelerate the development of new medical treatments for neurodegenerative conditions such …
National healthcare debate launched
September 15, 2005The first of four major events aimed at stimulating debate about the future of healthcare in the community has been …
PCTs, points and their progress
September 15, 2005The Quality and Outcomes Framework (QOF) is the cornerstone of the new GMS contract whereby practices achieve payment for achievement …
Handing over the reins of power
September 14, 2005Sales and Marketing
From poetry to patronage, finding a new chief executive for any pharma or biotech company can be a complicated business, …
Dealing with the generic threat
September 14, 2005Sales and Marketing
The looming spectre of generics is one which no pharma company with successful medicines on the market can afford to …
Postcode prescribing down to poor financial management, says report
September 13, 2005Postcode prescribing will only be eradicated if PCTs and NHS Trusts improve their financial management, according to a new report.The …
Connecting with customers
September 13, 2005Sales and Marketing
Great creative executions, those that have the 'wow' factor and stand out from the crowd, require long-term brand strategy and …
Exubera receives FDA vote of confidence
September 9, 2005Research and Development, Sales and Marketing
Exubera, the first inhaled insulin treatment for diabetes, has moved a step closer to US approval following recommendation approval from …
Pfizer and Sanofi battle challenges on patents
September 8, 2005Sales and Marketing
Two blockbuster drugs are facing key patent challenges on both sides of the Atlantic, with the outcome of the cases …
A far stricter code – but more scope for communication too
September 8, 2005Sales and Marketing
A much tighter UK pharmaceutical industry code of practice looks set to be introduced shortly, with a broad range of …
Industry braced for new upheaval in primary care
September 8, 2005Sales and Marketing NHS, PCTs, Pfizer
Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …
Merck’s problems deepen as MHRA reveals investigation
September 8, 2005Sales and Marketing
The controversy around the withdrawal of Vioxx has taken a new twist with news its manufacturer is being investigated for …
Pfizer to select seven for preferred supplier list
September 8, 2005Medical Communications
Pfizer is to limit the number of healthcare agencies it works with in the UK, as it looks to streamline …
GSK acquires vaccines research and manufacturing facility
September 8, 2005Manufacturing and Production, Research and Development
GlaxoSmithKline has acquired a vaccines R&D and manufacturing facility in the US, which it will use to develop its next …
New RA drug from BMS gains recommendation
September 7, 2005Sales and Marketing
A new treatment for rheumatoid arthritis from Bristol-Myers Squibb has received recommendation approval from an FDA committee, bringing it one …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
